The congress of European Society of Toxicology In Vitro (ESTIV) took place from 21st to 25th November 2022. This congress is focus on the alternative methods to animal testing, including both in silico and in vitro modeling. After a nice opening ceremony with a flamenco show, the scientific program begun Read more…
Last week we were pleased to attend the founding congress of STCM (Société de Toxicologie Cellularie et Moléculaire), which was held in FIAP Jean Monnet (Paris). The topic was “Toxicology towards the 3rd dimension“. With a wide variety of talks from academic laboratories and from the industry, the content was Read more…
The founding congress of the french STCM (Société de Toxicologie Cellulaire et Moléculaire) will take place in Paris at the end of this week (13th-14th June, 2019). The theme of this meeting will be “Toxicology towards the 3rd dimension“. We are looking forward to attending this congress, and to becoming Read more…
On November 7th, the 10th revision of the SCCS’s Notes of Guidance has been released. If you work in cosmetology, you know the importance of this document used to “provide guidance to public authorities and to the cosmetic industry in order to improve harmonised compliance with the current cosmetic EU Read more…
This year, the ESTIV (European Society of Toxicology In Vitro) congress took place in Berlin and was again a very interesting symposium. The plenary session was open by a presentation on 3D models made by bioengineering made by Paula Alves (Oireas/PT), and this year, a lot of presentations and poster were Read more…
Are your interested in meaning full images and high content analysis to asses your compounds properties ? Pierre-Jean, our dermocosmetic expert, will be present at Cosmetic 360 (the international trade fair for innovative ideas and solutions in the fragrance and cosmetics industry), 17th and 18th of October 2018 at Carrousel du Louvre in Read more…
The 20th International Congress on In Vitro Toxicology (ESTIV2018) is coming and it will be a great occasion for HCS-Pharma to showcase our current co-development, with the institute du thorax of Nantes and the RHU CHOPIN, on the use of hepatocyte-like cells differentiated from human induced pluripotent stem cells (hiPSC) Read more…
Every year around 10 millions of animals are used to assess compound’s safety, with a total cost estimated to 3 billions euro. Despite animal testing is mandatory by OECD to guarantee consumer safety, toxicologists are working on the development of alternative testing methods to solve this ethic and economic concern. Read more…
The first keynote of professor Philip Steven was a passionated overview of neurosciences between non-human and human research
HCS/HCA is a great way to predict drugs toxicity
This year, the ESTIV (European Society of Toxicology In Vitro) congress took place at Juan-les-Pins, from October 17 to October 20, and was about In Vitro Toxicology for Human Safety
We are very happy to present you Pierre-Jean Ferron, who joined HCS Pharma as a study director, specialized in cellular biology and high content analysis.
Genetic Engineering & Biotechnology News (GEN) organise a free webinar about HCS ans HCA use in drug toxicity and genotoxicity testing. High-content analysis (HCA) and high-content screening (HCS) enable imaging of large numbers of cellular samples for a variety of life science applications. Using automated high-resolution microscopy coupled with analytical Read more…